
Overview
Chenchao Liu is the founder and CEO of SILREAL, a consulting firm helping life-sciences and digital-health companies navigate policy, market access, and growth across Europe and China. He has advised global manufacturers, payers, and public institutions on reimbursement strategy, regulatory pathways, and commercial entry. Notable work includes leading a delegation program to China for the German Federal Ministry of Health and advising a leading hearing-care company on brand and market positioning in China. His recent analyses cover supply-chain resilience, demand forecasting for key therapeutic categories, data integration, and practical AI adoption. Chenchao holds a degree in chemistry from the Technical University of Munich and has collaborated with research institutes such as the Max Planck Society and ETH Zurich.
Publications
-
World Economic Forum – How the Belt and Road could help ageing populations (2021)
-
Neue Zürcher Zeitung (NZZ) – China und Covid-19
-
Handelsblatt Inside Digital Health – Featured contribution
-
Medical Science Publishing (MWV) – 360° Next Generation Healthcare (XPOMET)
-
Applied Physics Letters – Scientific publication from his research at TUM/ETH/Max-Planck Link
Speaking Engagements
-
2019 – Bayer Sino-European Digital Health Summit (Berlin)
-
2020 – Saarbrücker Gesundheitskongress SALUT! (Virtual)
-
2021 – Sino-European Health Summit (AsiaBerlin Summit, Berlin)
-
2022 – German Federal Ministry of Health Delegation to China (Beijing, Shanghai, Shenzhen)
-
2023 – EFPIA Conference
-
2024 – European China Conference (Berlin, via MERICS)
-
2024 – Institute for Communication & Leadership (Lucerne) Lecturer for “Digital Health China” module (two semesters).



